The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package

• Үндсэн зохиолчид: Anothaisintawee T (Зохиогч), Leelahavarong P (Зохиогч), Ratanapakorn T (Зохиогч), Teerawattananon Y (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Dove Medical Press, 2012-12-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Thunyarat Anothaisintawee,1,2 Pattara Leelahavarong,1 Tanapat Ratanapakorn,3 Yot Teerawattananon11Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand; 2Family Medicine Department and Section of Clinical Epidemiology and Biostatistics, Ramathibodi Ho...